Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

1.

Prostate cancer treatment for economically disadvantaged men: a comparison of county hospitals and private providers.

Parsons JK, Kwan L, Connor SE, Miller DC, Litwin MS.

Cancer. 2010 Mar 1;116(5):1378-84. doi: 10.1002/cncr.24856.

PMID:
20101733
[PubMed - indexed for MEDLINE]
Free Article
2.

Quality of prostate carcinoma care in a statewide public assistance program.

Krupski TL, Bergman J, Kwan L, Litwin MS.

Cancer. 2005 Sep 1;104(5):985-92.

PMID:
16047332
[PubMed - indexed for MEDLINE]
Free Article
3.

Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).

Kawakami J, Cowan JE, Elkin EP, Latini DM, DuChane J, Carroll PR; CaPSURE Investigators.

Cancer. 2006 Apr 15;106(8):1708-14.

PMID:
16544313
[PubMed - indexed for MEDLINE]
Free Article
4.

Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleason score 8 or above.

Kupelian PA, Buchsbaum JC, Elshaikh M, Reddy CA, Zippe C, Klein EA.

Cancer. 2002 Dec 1;95(11):2302-7.

PMID:
12436435
[PubMed - indexed for MEDLINE]
Free Article
5.

Biochemical outcomes after prostate brachytherapy with 5-year minimal follow-up: importance of patient selection and implant quality.

Kollmeier MA, Stock RG, Stone N.

Int J Radiat Oncol Biol Phys. 2003 Nov 1;57(3):645-53.

PMID:
14529768
[PubMed - indexed for MEDLINE]
6.

Prostate brachytherapy: a descriptive analysis from CaPSURE.

Lee WR, Sharkey J, Cowan JE, DuChane J, Carroll PR; CaPSURE Investigators.

Brachytherapy. 2007 Apr-Jun;6(2):123-8.

PMID:
17434105
[PubMed - indexed for MEDLINE]
7.

The 1999 patterns of care study of radiotherapy in localized prostate carcinoma: a comprehensive survey of prostate brachytherapy in the United States.

Lee WR, Moughan J, Owen JB, Zelefsky MJ.

Cancer. 2003 Nov 1;98(9):1987-94.

PMID:
14584083
[PubMed - indexed for MEDLINE]
Free Article
8.

A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy.

Lee WR, Hall MC, McQuellon RP, Case LD, McCullough DL.

Int J Radiat Oncol Biol Phys. 2001 Nov 1;51(3):614-23.

PMID:
11597800
[PubMed - indexed for MEDLINE]
9.

Prostate cancer: socio-economic, geographical and private-health insurance effects on care and survival.

Hall SE, Holman CD, Wisniewski ZS, Semmens J.

BJU Int. 2005 Jan;95(1):51-8.

PMID:
15638894
[PubMed - indexed for MEDLINE]
10.

Outcomes in men denied access to a California public assistance program for prostate cancer.

Anger JT, Maliski SL, Krupski TL, Kwan L, Gore JL, Fink A, Connor SE, Orecklin JR, Litwin MS.

Public Health Rep. 2007 Mar-Apr;122(2):217-23.

PMID:
17357364
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Race as an independent predictor of outcome after treatment for localized prostate cancer.

Sohayda CJ, Kupelian PA, Altsman KA, Klein EA.

J Urol. 1999 Oct;162(4):1331-6.

PMID:
10492191
[PubMed - indexed for MEDLINE]
12.

Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime.

Martinez AA, Demanes DJ, Galalae R, Vargas C, Bertermann H, Rodriguez R, Gustafson G, Altieri G, Gonzalez J.

Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1322-31.

PMID:
16029788
[PubMed - indexed for MEDLINE]
13.

Higher than standard radiation doses (> or =72 Gy) with or without androgen deprivation in the treatment of localized prostate cancer.

Kupelian PA, Mohan DS, Lyons J, Klein EA, Reddy CA.

Int J Radiat Oncol Biol Phys. 2000 Feb 1;46(3):567-74.

PMID:
10701735
[PubMed - indexed for MEDLINE]
14.

Treatment choice and quality of care for men with localized prostate cancer.

Miller DC, Spencer BA, Ritchey J, Stewart AK, Dunn RL, Sandler HM, Wei JT, Litwin MS.

Med Care. 2007 May;45(5):401-9.

PMID:
17446826
[PubMed - indexed for MEDLINE]
15.

Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancer.

Gallina A, Karakiewicz PI, Chun FK, Briganti A, Graefen M, Montorsi F, Walz J, Jeldres C, Erbersdobler A, Salonia A, Suardi N, Dehò F, Schlomm T, Scattoni V, Haese A, Heinzer H, Valiquette L, Rigatti P, Huland H.

BJU Int. 2007 Jun;99(6):1404-8. Epub 2007 Apr 8.

PMID:
17428250
[PubMed - indexed for MEDLINE]
16.

Determinants of treatment regret in low-income, uninsured men with prostate cancer.

Hu JC, Kwan L, Krupski TL, Anger JT, Maliski SL, Connor S, Litwin MS.

Urology. 2008 Dec;72(6):1274-9. doi: 10.1016/j.urology.2007.11.066. Epub 2008 Mar 3.

PMID:
18313115
[PubMed - indexed for MEDLINE]
17.

Gleason Pattern 5 prostate cancer: further stratification of patients with high-risk disease and implications for future randomized trials.

Nanda A, Chen MH, Renshaw AA, D'Amico AV.

Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1419-23. doi: 10.1016/j.ijrobp.2008.10.027. Epub 2009 Jan 7.

PMID:
19131185
[PubMed - indexed for MEDLINE]
18.

Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era.

Kupelian P, Thames H, Levy L, Horwitz E, Martinez A, Michalski J, Pisansky T, Sandler H, Shipley W, Zelefsky M, Zietman A, Kuban D.

Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):795-9. Epub 2005 May 31.

PMID:
15925452
[PubMed - indexed for MEDLINE]
19.

Additional treatments and reimbursement rates associated with prostate cancer treatment for patients undergoing radical prostatectomy, interstitial brachytherapy, and external beam radiotherapy.

Goharderakhshan RZ, Grossfeld GD, Kassis A, Shinohara K, Roach M, Carroll PR.

Urology. 2000 Oct 1;56(4):622-6.

PMID:
11018618
[PubMed - indexed for MEDLINE]
20.

Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy.

Potosky AL, Reeve BB, Clegg LX, Hoffman RM, Stephenson RA, Albertsen PC, Gilliland FD, Stanford JL.

J Natl Cancer Inst. 2002 Mar 20;94(6):430-7.

PMID:
11904315
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk